Tarveda Therapeutics
Tarveda’s lead Pentarin drug candidate, PEN-221, is a miniaturized drug conjugate that targets the somatostatin receptor 2 (SSTR2) for treatment of patients with neuroendocrine and small cell lung cancers.
Mymetics
Mymetics is a biotechnology company focused on the development of innovative prophylactic vaccines for infectious and life-disabling diseases using its proprietary virosome-based technology. Their research targets a range of diseases including HIV-1/AIDS, malaria, respiratory syncytial virus (RSV), and chikungunya, aiming to provide protection against early transmission and infection.
Espero BioPharma
ESPERO supports the life science industry to accelerate the delivery of therapies to patients by tackling inefficiencies in protocol creation and implementation.
Revelar BT
Developer of therapeutic antibody products designed to address critical unmet patient needs for COVID-19 and other therapeutic areas.